Authors:
Aukrust, P
Muller, F
Ueland, T
Svardal, AM
Berge, RK
Froland, SS
Citation: P. Aukrust et al., Decreased vitamin A levels in common variable immunodeficiency: vitamin A supplementation in vivo enhances immunoglobulin production and downregulates inflammatory responses, EUR J CL IN, 30(3), 2000, pp. 252-259
Authors:
Muller, F
Svardal, AM
Nordoy, I
Berge, RK
Aukrust, P
Froland, SS
Citation: F. Muller et al., Virological and immunological effects of antioxidant treatment in patientswith HIV infection, EUR J CL IN, 30(10), 2000, pp. 905-914
Authors:
Nordoy, I
Muller, F
Nordal, KP
Rollag, H
Aukrust, P
Froland, SS
Citation: I. Nordoy et al., Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection, CLIN EXP IM, 120(2), 2000, pp. 333-337
Authors:
Stylianou, E
Aukrust, P
Bendtzen, K
Muller, F
Froland, SS
Citation: E. Stylianou et al., Interferons and interferon (IFN)-inducible protein 10 during highly activeanti-retroviral therapy (HAART) - possible immunosuppressive role of IFN-alpha in HIV infection, CLIN EXP IM, 119(3), 2000, pp. 479-485
Authors:
Damas, JK
Eiken, HG
Oie, E
Bjerkeli, V
Yndestad, A
Ueland, T
Tonnessen, T
Geiran, OR
Aass, H
Simonsen, S
Christensen, G
Froland, SS
Attramadal, H
Gullestad, L
Aukrust, P
Citation: Jk. Damas et al., Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure, CARDIO RES, 47(4), 2000, pp. 778-787
Authors:
Damas, JK
Gullestad, L
Ueland, T
Solum, NO
Simonsen, S
Froland, SS
Aukrust, P
Citation: Jk. Damas et al., CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes, CARDIO RES, 45(2), 2000, pp. 428-436
Citation: P. Aukrust et F. Muller, Glutathione redox disturbances in human immunodeficiency virus infection: Immunologic and therapeutic consequences, NUTRITION, 15(2), 1999, pp. 165-167
Authors:
Gullestad, L
Aukrust, P
Ueland, T
Espevik, T
Yee, G
Vagelos, R
Froland, SS
Fowler, M
Citation: L. Gullestad et al., Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure, J AM COL C, 34(7), 1999, pp. 2061-2067
Authors:
Kvale, D
Aukrust, P
Osnes, K
Muller, F
Froland, SS
Citation: D. Kvale et al., CD4+ and CD8+ lymphocytes and HIV RNA in HIV infection: high baseline counts and in particular rapid decrease of CD8+ lymphocytes predict AIDS, AIDS, 13(2), 1999, pp. 195-201
Authors:
Aandahl, EM
Aukrust, P
Muller, F
Hansson, V
Tasken, K
Froland, SS
Citation: Em. Aandahl et al., Additive effects of IL-2 and protein kinase A type I antagonist on function of T cells from HIV-infected patients on HAART, AIDS, 13(17), 1999, pp. F109-F114
Authors:
Nordoy, I
Muller, F
Nordal, KP
Rollag, H
Lien, E
Aukrust, P
Froland, SS
Citation: I. Nordoy et al., Immunologic parameters as predictive factors of cytomegalovirus disease inrenal allograft recipients, J INFEC DIS, 180(1), 1999, pp. 195-198
Authors:
Aukrust, P
Muller, F
Lien, E
Nordoy, I
Liabakk, NB
Kvale, D
Espevik, T
Froland, SS
Citation: P. Aukrust et al., Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: Persistent TNF activation is associated with virologic and immunologic treatment failure, J INFEC DIS, 179(1), 1999, pp. 74-82
Authors:
Aukrust, P
Aandahl, EM
Skalhegg, BS
Nordoy, I
Hansson, V
Tasken, K
Froland, SS
Muller, F
Citation: P. Aukrust et al., Increased activation of protein kinase a type I contributes to the T cell deficiency in common variable immunodeficiency, J IMMUNOL, 162(2), 1999, pp. 1178-1185
Authors:
Aukrust, P
Haug, CJ
Ueland, T
Lien, E
Muller, F
Espevik, T
Bollerslev, J
Froland, SS
Citation: P. Aukrust et al., Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy, J CLIN END, 84(1), 1999, pp. 145-150
Authors:
Stylianou, E
Aukrust, P
Kvale, D
Muller, F
Froland, SS
Citation: E. Stylianou et al., IL-10 in HIV infection: increasing serum IL-10 levels with disease progression - down-regulatory effect of potent anti-retroviral therapy, CLIN EXP IM, 116(1), 1999, pp. 115-120
Authors:
Aukrust, P
Muller, F
Svenson, M
Nordoy, I
Bendtzen, K
Froland, SS
Citation: P. Aukrust et al., Administration of intravenous immunoglobulin (IVIG) in vivo-down-regulatory effects on the IL-1 system, CLIN EXP IM, 115(1), 1999, pp. 136-143
Authors:
Aukrust, P
Muller, F
Ueland, T
Berget, T
Aaser, E
Brunsvig, A
Solum, NO
Forfang, K
Froland, SS
Gullestad, L
Citation: P. Aukrust et al., Enhanced levels of soluble and membrane-bound CD40 ligand in patients withunstable angina - Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes, CIRCULATION, 100(6), 1999, pp. 614-620
Authors:
Gullestad, L
Simonsen, S
Ueland, T
Holm, T
Aass, H
Andreassen, AK
Madsen, S
Geiran, O
Froland, SS
Aukrust, P
Citation: L. Gullestad et al., Possible role of proinflammatory cytokines in heart allograft coronary artery disease, AM J CARD, 84(9), 1999, pp. 999-1003
Authors:
Aukrust, P
Ueland, T
Lien, E
Bendtzen, K
Muller, F
Andreassen, AK
Nordoy, I
Aass, H
Espevik, T
Simonsen, S
Froland, SS
Gullestad, L
Citation: P. Aukrust et al., Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy, AM J CARD, 83(3), 1999, pp. 376-382